Early Screening of Hepatocellular Carcinoma in Cirrhotic Patients: a Prospective Study

This study is currently recruiting participants.

Verified by Kaohsiung Medical University Chung-Ho Memorial Hospital, July 2007

Sponsored by:	Kaohsiung Medical University Chung-Ho Memorial Hospital
Information provided by:	Kaohsiung Medical University Chung-Ho Memorial Hospital
ClinicalTrials.gov Identifier:	NCT00629421

Purpose

Although serum alpha-fetoprotein level and abdominal sonography are the main methods to screening hepatocellular carcinoma (HCC) in cirrhotic patients, the adequate time and methods used are not completely well-defined. This study aims to assess the better timing and methods for prospectively screening HCC in patients with cirrhosis

Condition
Cirrhosis Hepatocellular Carcinoma

MedlinePlus related topics: Cirrhosis

U.S. FDA Resources

Study Type:	Observational
Study Design:	Prospective
Official Title:	Early Screening of Hepatocellular Carcinoma in Cirrhotic Patients: a Prospective Study

Further study details as provided by Kaohsiung Medical University Chung-Ho Memorial Hospital:

Study Start Date:	January 2001
Estimated Study Completion Date:	December 2010

Eligibility

Genders Eligible for Study:

Both

Criteria

Inclusion Criteria:

Image diagnosis or biochemical diagnosis or presence of portal hypertension

Exclusion Criteria:

Presence of hepatocellular carcinoma

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00629421

Contacts

Contact: Jung-Fa Tsai, M.D., Ph.D.

886-7-3121101 ext 7475

jftsai@cc.kmu.edu.tw

Locations

Taiwan
Kaohsiung Medical University Chung-Ho Memorial Hospital	Recruiting
Kaohsiung, Taiwan, 807
Principal Investigator: Jung-Fa Tsai, M.D., Ph.D.

Sponsors and Collaborators

Kaohsiung Medical University Chung-Ho Memorial Hospital

Investigators

Principal Investigator:

Jung-Fa Tsai, M.D., Ph.D.

Kaohsiung Medical University

More Information

Study ID Numbers:	KMUH-IRB-960012
Study First Received:	February 26, 2008
Last Updated:	March 5, 2008
ClinicalTrials.gov Identifier:	NCT00629421
Health Authority:	Taiwan: Department of Health

Study placed in the following topic categories:

Liver Diseases
Digestive System Neoplasms
Carcinoma, Hepatocellular
Fibrosis
Liver neoplasms
Liver Cirrhosis
Carcinoma

Liver Neoplasms
Digestive System Diseases
Gastrointestinal Neoplasms
Adenocarcinoma
Neoplasms, Glandular and Epithelial
Hepatocellular carcinoma

Additional relevant MeSH terms:

Neoplasms
Pathologic Processes
Neoplasms by Site
Neoplasms by Histologic Type

ClinicalTrials.gov processed this record on January 16, 2009